Skip to content
Men Under Microscope – Lifestyle
Author:
Chemomab Therapeutics Ltd.
Chemomab Therapeutics and Scipher Medicine Announce SEC Registration Statement on Form S-4 Is Effective
November 2, 2026
Chemomab Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update
August 19, 2026
Chemomab Therapeutics and Precision Medicine Pioneer Scipher Medicine Announce Merger Agreement to Advance Nebokitug in an AI-Powered Phase 2 Trial in Rheumatoid Arthritis
July 8, 2026
Chemomab Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update
May 14, 2026